Trans-Synaptic Spread of Amyloid-β in Alzheimer's Disease: Paths to β-Amyloidosis

被引:20
|
作者
Pignataro, Annabella [1 ]
Middei, Silvia [1 ,2 ]
机构
[1] Santa Lucia Fdn, Lab Psychobiol, Dept Expt Neurol, Via Fosso Fiorano, I-00143 Rome, Italy
[2] Natl Res Ctr, Inst Cell Biol & Neurobiol, Via E Ramarini, I-00040 Rome, Italy
关键词
A-BETA; FUNCTIONAL CONNECTIVITY; REGIONAL VULNERABILITY; AEROBIC GLYCOLYSIS; DEFAULT NETWORK; BRAIN ACTIVITY; LONG-TERM; DEPOSITION; PROTEIN; APP;
D O I
10.1155/2017/5281829
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuronal activity has a strong causal role in the production and release of the neurotoxic beta-amyloid peptide (A beta). Because of this close link, gradual accumulation of A beta into amyloid plaques has been reported in brain areas with intense neuronal activity, including cortical regions that display elevated activation at resting state. However, the link between A beta and activity is not always linear and recent studies report exceptions to the view of "more activity, more plaques." Here, we review the literature about the activity-dependent production of A beta in both human cases and AD models and focus on the evidences that brain regions with elevated convergence of synaptic connections (herein referred to as brain nodes) are particularly vulnerable to A beta accumulation. Next, we will examine data supporting the hypothesis that, since A beta is released from synaptic terminals, beta-amyloidosis can spread in AD brain by advancing through synaptically connected regions, which makes brain nodes vulnerable to A beta accumulation. Finally, we consider possible mechanisms that account for beta-amyloidosis progression through synaptically linked regions.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Alzheimer's disease: the ins and outs of amyloid-β
    Beyreuther, Konrad
    Masters, Colin L.
    Nature, 1997, 389 (6652):
  • [32] Aluminum and Amyloid-β in Familial Alzheimer's Disease
    Mold, Matthew
    Linhart, Caroline
    Gomez-Ramirez, Johana
    Villegas-Lanau, Andres
    Exley, Christopher
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (04) : 1627 - 1635
  • [33] Amyloid-β: A double agent in Alzheimer's disease?
    Yu, Hao
    Wu, Jie
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [34] Citrullination of Amyloid-β Peptides in Alzheimer's Disease
    Mukherjee, Soumya
    Perez, Keyla A.
    Dubois, Celine
    Nisbet, Rebecca M.
    Li, Qiao-Xin
    Varghese, Shiji
    Jin, Liang
    Birchall, Ian
    Streltsov, Victor A.
    Vella, Laura J.
    McLean, Catriona
    Barham, Kevin J.
    Roberts, Blaine R.
    Masters, Colin L.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (19): : 3719 - 3732
  • [35] Amyloid-β-directed immunotherapy for Alzheimer's disease
    Lannfelt, L.
    Relkin, N. R.
    Siemers, E. R.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (03) : 284 - 295
  • [36] Amyloid-β and Glucose Metabolism in Alzheimer's Disease
    Furst, Ansgar J.
    Lal, Rayhan A.
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 : 105 - 116
  • [37] Role of Mitochondrial Amyloid-β in Alzheimer's Disease
    Chen, John Xi
    Yan, Shirley Shidu
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S569 - S578
  • [38] Amyloid-β and Tau at the Crossroads of Alzheimer's Disease
    Gallardo, Gilbert
    Holtzman, David M.
    TAU BIOLOGY, 2019, 1184 : 187 - 203
  • [39] Amyloid-β-targeting immunotherapies for Alzheimer's disease
    Jin, Yi
    Du, Qiaofei
    Song, Mingjie
    Kang, Ruixin
    Zhou, Jianping
    Zhang, Huaqing
    Ding, Yang
    JOURNAL OF CONTROLLED RELEASE, 2024, 375 : 346 - 365
  • [40] Soluble Amyloid-β Consumption in Alzheimer's Disease
    Espay, Alberto J.
    Sturchio, Andrea
    Schneider, Lon S.
    Ezzat, Kariem
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 (04) : 1403 - 1415